🇺🇸 FDA

Intelligence Platform

Patents

Browse 2,828 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 6090840

Peptidyl compounds having MMP and TNF inhibitory activity

Darwin Discovery Limited · Granted Tue Jul 18 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 13 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6087384

Apoptosis inhibitor

Takeda Chemical Industries Ltd. · Granted Tue Jul 11 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 06 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6084063

Signal transduction inhibitors of allergic reactions

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jul 04 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 29 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6075044

Heterocyclic derivatives as inhibitors of purine salvage phosphoribosyltransferases

The Regents of the University of California · Granted Tue Jun 13 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 08 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6075014

Inhibitors of .beta.-lactamases and uses therefor

Northwestern University · Granted Tue Jun 13 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 08 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6071509

Enhanced activation of natural killer cells using an NK cell activator and a hydrogen pero

Maxim Pharmaceuticals, Inc. · Granted Tue Jun 06 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6071949

Use of lipoxygenase inhibitors as anti-cancer therapeutic and intervention agents

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jun 06 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6069130

Ketoheterocyclic inhibitors of factor Xa

COR Therapeutics, Inc. · Granted Tue May 30 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 25 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6063794

Selective factor Xa inhibitors

COR Therapeutics, Inc. · Granted Tue May 16 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6063373

Enhanced activation of NK cells using an NK cell activator and a hydrogen peroxide scaveng

Maxim Pharmaceuticals, Inc. · Granted Tue May 16 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6060310

Transcription factor decoy and tumor growth inhibitor

The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 09 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6060500

Suppression, by 5-lipoxygenase inhibitors, of bone resorption

The Board of Regents of the University of Texas System · Granted Tue May 09 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6054472

Inhibitors of IMPDH enzyme

Vertex Pharmaceuticals Incorporated · Granted Tue Apr 25 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 20 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6046169

Inhibitors of factor XA

COR Therapeutics, Inc. · Granted Tue Apr 04 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 30 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6046175

Procedure to block the replication of reverse transcriptase dependent viruses by the use o

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Apr 04 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 30 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6040340

Implantation rates after in vitro fertilization, treatment of infertility and early pregna

The Board of Regents, Univ. of Texas System · Granted Tue Mar 21 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 16 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6040334

Use of inhibitors of 3-hydroxy-3-methylglutaryl coenzyme a reductase as a modality in canc

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Mar 21 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 16 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6034255

Inhibitors of cholesterol esterase

The Regents of the University of New Mexico · Granted Tue Mar 07 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 02 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6025147

Inhibitors of interleukin-1 .beta. converting enzyme

Vertex Pharmaceuticals Incorporated · Granted Tue Feb 15 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6022861

Ketoheterocyclic inhibitors of factor Xa

COR Therapeutics, Inc. · Granted Tue Feb 08 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 03 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired